Sage Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2014 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sage Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2014 to Q3 2024.
  • Sage Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 22, 2024 was 61.2M shares, a 2.01% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 61.2M +1.21M +2.01% Oct 22, 2024 10-Q 2024-10-29
Q2 2024 61.1M +1.17M +1.95% Jul 24, 2024 10-Q 2024-07-31
Q1 2024 60.2M +420K +0.7% Apr 18, 2024 10-Q 2024-04-25
Q4 2023 60.1M +389K +0.65% Feb 7, 2024 10-K 2024-02-14
Q3 2023 60M +474K +0.8% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 59.9M +462K +0.78% Aug 1, 2023 10-Q 2023-08-07
Q1 2023 59.8M +696K +1.18% Apr 25, 2023 10-Q 2023-05-02
Q4 2022 59.7M Feb 8, 2023 10-K 2023-02-16
Q3 2022 59.5M +585K +0.99% Nov 1, 2022 10-Q 2022-11-08
Q2 2022 59.4M +611K +1.04% Jul 27, 2022 10-Q 2022-08-02
Q1 2022 59.1M +586K +1% Apr 26, 2022 10-Q 2022-05-03
Q3 2021 58.9M +6.86M +13.2% Oct 26, 2021 10-Q 2021-11-02
Q2 2021 58.8M +6.84M +13.2% Jul 27, 2021 10-Q 2021-08-03
Q1 2021 58.5M +6.56M +12.6% Apr 27, 2021 10-Q 2021-05-04
Q3 2020 52M +227K +0.44% Oct 29, 2020 10-Q 2020-11-05
Q2 2020 52M +317K +0.61% Aug 4, 2020 10-Q 2020-08-10
Q1 2020 51.9M +770K +1.51% Apr 30, 2020 10-Q 2020-05-07
Q3 2019 51.8M +4.93M +10.5% Nov 6, 2019 10-Q 2019-11-12
Q2 2019 51.7M +4.99M +10.7% Jul 31, 2019 10-Q 2019-08-06
Q1 2019 51.1M +4.63M +9.96% Apr 25, 2019 10-Q 2019-05-02
Q4 2018 47.1M Feb 12, 2019 10-K 2019-02-19
Q3 2018 46.9M +9.35M +24.9% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 46.7M +9.22M +24.6% Aug 1, 2018 10-Q 2018-08-07
Q1 2018 46.5M +9.17M +24.6% Apr 26, 2018 10-Q 2018-05-03
Q3 2017 37.5M +370K +1% Oct 30, 2017 10-Q 2017-11-02
Q2 2017 37.4M +5.35M +16.7% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 37.3M +5.28M +16.5% May 3, 2017 10-Q 2017-05-10
Q3 2016 37.2M +8.3M +28.8% Nov 1, 2016 10-Q 2016-11-03
Q2 2016 32.1M +3.27M +11.4% Aug 1, 2016 10-Q 2016-08-09
Q1 2016 32.1M +6.25M +24.2% Apr 29, 2016 10-Q 2016-05-06
Q3 2015 28.9M +3.07M +11.9% Nov 1, 2015 10-Q 2015-11-06
Q2 2015 28.8M +3.11M +12.1% Aug 1, 2015 10-Q 2015-08-12
Q1 2015 25.8M Mar 1, 2015 10-K 2015-03-06
Q3 2014 25.8M Nov 1, 2014 10-Q 2014-11-13
Q2 2014 25.7M Aug 1, 2014 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.